Related Experiment Video
Updated: Aug 1, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
The Length of Hospital Stay of Patients with Venous Thromboembolism: A Cross-Sectional Study from Jordan
Haneen Amawi1, Rasha M Arabyat1, Sayer Al-Azzam2
1Department of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Yarmouk University, Irbid 22110, Jordan.
Insights
Venous thromboembolism (VTE) patients in Jordan often have long hospital stays, with nearly half hospitalized for 7 days or more. Hypertension was a key factor linked to longer lengths of stay (LOS).
Area of Science:
- Cardiology
- Public Health
- Pharmacology
Background:
- Venous thromboembolism (VTE) is a significant global health concern, contributing to mortality and disability.
- Effective anticoagulation therapy is crucial for managing VTE and optimizing patient outcomes, including hospital length of stay (LOS).
- Understanding VTE patient demographics and treatment patterns in specific regions, like Jordan, is essential for improving care.
Purpose of the Study:
- To determine the length of hospital stay (LOS) among patients diagnosed with acute venous thromboembolism (VTE).
- To identify predictors associated with prolonged hospital stays in VTE patients.
- To inform treatment strategies and healthcare resource allocation for VTE management in Jordan.
Main Methods:
- A cohort of 317 hospitalized patients with confirmed VTE diagnoses was recruited.
- Data collection involved reviewing electronic medical records, patient charts, and conducting patient surveys.
- Hospital LOS was categorized (1-3 days, 4-6 days, ≥7 days), and an ordered logistic regression model was employed to identify significant predictors.
Main Results:
- The study included 317 VTE patients; 52.4% were male, and 35.3% were aged 50-69.
- Deep vein thrombosis (DVT) was the most common diagnosis (84.2%), with 64.6% of cases being first-time admissions.
- Hypertension (59%) and obesity (66.3%) were prevalent comorbidities. Almost half (45%) of patients had an LOS of ≥7 days.
- Hypertension was identified as a significant predictor of longer hospital LOS.
Conclusions:
- A substantial proportion of VTE patients in Jordan experience prolonged hospitalizations, highlighting a need for optimized treatment protocols.
- Therapies like direct oral anticoagulants (DOACs) or non-vitamin K antagonist oral anticoagulants (NOACs) may help reduce hospital LOS.
- Effective management of comorbidities, particularly hypertension, is critical for improving VTE patient outcomes and reducing healthcare burdens.
Abstract:
Background and Objectives: Venous thromboembolism is one of the leading causes of mortality and disability worldwide. Treatment with anticoagulation therapy is essential and requires a delicate approach to select the most appropriate option to improve patient outcomes, including the length of hospital stay (LOS). The aim of this study was to determine the LOS among patients with acute onset of VTE in several public hospitals in Jordan. Materials and Methods: In this study, we recruited hospitalized patients with a confirmed diagnosis of VTE. We reviewed the electronic medical records and charts of VTE admitted patients in addition to a detailed survey to collect the patients' self-reported data. Hospital LOS was categorized into three levels: 1-3 days, 4-6 days, and ≥7 days. An ordered logistic regression model was used to study the significant predictors of LOS. Results: A total of 317 VTE patients were recruited, with 52.4% of them were male and 35.3% aged between 50 and 69 years. Most patients had a deep vein thrombosis (DVT) diagnosis (84.2%), and most of the VTE cases were admitted for the first-time (64.6%). The majority of the patients were smokers (57.2%), overweight/obese (66.3%), and hypertensive (59%). Most of the VTE patients received Warfarin overlapped with low molecular weight heparins as their treatment regimen (>70%). Almost half of the admitted VTE patients (45%) were hospitalized for at least 7 days. Longer LOS was significantly associated with hypertension. Conclusions: We recommend using therapies that have been proven to reduce hospital LOS, such as non-vitamin K antagonist oral anticoagulants or direct oral anticoagulants, to treat VTE patients in Jordan. Additionally, preventing and controlling comorbidities such as hypertension is essential.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction

